Lungs in Medical Technology
Navigation Links
Lungs in Medical Technology
... perception that medication
went into the lungs (p<0.028). Overall, subjects perceived more ... lung disorders in which the airways
in the lungs become narrowed and breathing becomes ... method of delivering medicine directly into the lungs for
patients, particularly as their symptoms ...
... that chymase-positive mast cells primarily located in the distal lungs play a crucial role in asthma. This requires delivery of DSCG via small droplets to the target site in the lungs and can be best achieved by a highly efficient nebulizer, such as the ...
... including Pseudomonas aeruginosa. Delivery of levofloxacin directly to the lungs of CF patients by the aerosol route can potentially provide a number of ... Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug directly to ...
... refers to a number of chronic lung disorders in which the airways to the lungs become narrowed and breathing becomes increasingly difficult. The most ... is an easy and effective method of delivering medicine directly into the lungs for patients, particularly as their symptoms worsen.(3) With ...
... refers to a number of chronic lung disorders in which the airways to the lungs become narrowed and breathing becomes increasingly difficult. The most ... is an easy and effective method of delivering medicine directly into the lungs for patients, particularly as their symptoms worsen.(3) With ...
... of patients with CF, bacteria called Burkholderia cenocepacia infects the lungs before transplant. This infection is very resistant to antibiotics and if ... debate within the transplant community is whether or not to allocate donor lungs to patients with Burkholderia cenocepacia knowing that the success rate is ...
... results suggest the potential to immediately increase the number of lungs available for transplantation. Although thousands of patients are on lung ... of individuals identified as organ donors actually have suitable lungs for transplantation. During the ISHLT mini-oral session I: The Non-Heart ...
... should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If your asthma symptoms do not improve, or get worse, contact your health ...
... should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If your asthma symptoms do not improve, or get worse, contact your health ...
... accounting for more than $13 billion in hospitalization costs. The great majority of acute heart failure patients have fluid accumulation in the lungs (congestion) that causes shortness of breath (dyspnea) and other complications. For these patients, the current standard of care includes diuretics ...
... accounting for a total of $13 billion in hospitalization costs. The great majority of acute heart failure patients have fluid accumulation in the lungs (congestion) that causes shortness of breath and other complications. For these patients, the current standard of care includes diuretics and ...
... drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort ...
... drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort ...
... forms in a major vein of the leg, and pulmonary embolism, which occurs when a blood clot detaches from its point of origin and travels to the lungs where it becomes wedged and prevents adequate blood flow, are known collectively as venous thromboembolism. "Venous thromboembolism is a ...
... stage research with imatinib mesylate in another non-oncology disease called idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become scarred over time, making it more and more difficult to breathe(6). Early clinical trial results in IPF did not show a significant ...
... from $23 billion in 2007 to $46 billion by 2017. Vectura also develops products for non-respiratory diseases where optimised delivery via the lungs could provide significant benefits, such as a rapid onset of action, improved efficacy and improved tolerability compared with current therapies. ...
... heart rate -- all of which are symptoms often seen in HF patients, but in many cases, can be managed with medication. The back pressure in the lungs due to the inability of the heart to pump the blood effectively can be measured and transmitted by this device. With this system, pressure data is ...
... When stimulated by the NeuRx DPS(TM), the diaphragm contracts, mimicking natural breathing, and allows air to fill the upper and lower parts of the lungs rather than forcing air in with a mechanical ventilator. The NeuRx DPS(TM) received the CE Mark (CE Registration #518356) on November 20, 2007 and ...
... the potential value of delivering amikacin through Transave's next-generation liposomal technology." The biofilm is a gel-like matrix in the lungs formed by colonies of the common and often chronic bacterium Pseudomonas aeruginosa, which creates a protective barrier for the bacteria. This ...
Amikacin Inhale Shows Promising Results in Phase II Study
... reach effective concentrations in infected lungs at tolerable doses. The new study data shows that ... 43 percent of the dose was delivered to the lungs using the hand-held system with a comparable low systemic exposure. The dose delivered to the lungs with the proprietary nebulizer is comparable ...NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
... disease caused by chronic inflammation of the lungs and bronchi and represents the third-leading ... of air that can be forcibly expelled from the lungs after breathing in as deeply as possible and ... of air that can be forcibly expelled from the lungs after breathing in as deeply as possible and ...Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease
... roles is to shield the delicate tissues of the lungs by binding to neutrophil elastase, an ... the neutrophil elastase released to protect the lungs is uncontrolled and can injure healthy lung tissue. Repeated injury to the normal structure of the lungs can eventually result in emphysema, a condition ...... that chymase-positive mast cells primarily located in the distal lungs play a crucial role in asthma. This requires delivery of DSCG via small droplets to the target site in the lungs and can be best achieved by a highly efficient nebulizer, such as the ...
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
... proprietary dry-powder mannitol, precision formulated for delivery to the lungs through an easy-to-use, pocket-size, portable inhaler. Once inhaled its ... particular, Bronchitol has been shown to increase mucus clearance from the lungs and significantly improve quality of life for people with bronchiectasis. ...Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis
... and panresistant (completely resistant) bacteria obtained from the lungs of patients with cystic fibrosis. All strains of bacteria except two were ... can nebulize our nanoemulsion so that it is deposited directly into the lungs to kill these highly resistant infections that cannot be effectively ...The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
... that causes the body to produce thick, sticky mucus, which clogs the lungs and leads to life-threatening lung infections. Several years ago, ... saltwater mist has a powerful effect on rehydrating the lining of the lungs and allowing CF patients to more easily eliminate bacteria-contaminated ...Pulmo BioTech Inc. Completes Bio-Distribution Studies
... vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention (~ 1/10th) in the ... allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently ...... including Pseudomonas aeruginosa. Delivery of levofloxacin directly to the lungs of CF patients by the aerosol route can potentially provide a number of ... Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug directly to ...
... refers to a number of chronic lung disorders in which the airways to the lungs become narrowed and breathing becomes increasingly difficult. The most ... is an easy and effective method of delivering medicine directly into the lungs for patients, particularly as their symptoms worsen.(3) With ...
... refers to a number of chronic lung disorders in which the airways to the lungs become narrowed and breathing becomes increasingly difficult. The most ... is an easy and effective method of delivering medicine directly into the lungs for patients, particularly as their symptoms worsen.(3) With ...
... of patients with CF, bacteria called Burkholderia cenocepacia infects the lungs before transplant. This infection is very resistant to antibiotics and if ... debate within the transplant community is whether or not to allocate donor lungs to patients with Burkholderia cenocepacia knowing that the success rate is ...
... results suggest the potential to immediately increase the number of lungs available for transplantation. Although thousands of patients are on lung ... of individuals identified as organ donors actually have suitable lungs for transplantation. During the ISHLT mini-oral session I: The Non-Heart ...
Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
... system commonly used to deliver airflow and pressure to an infant's lungs via short prongs in the nose. This air pressure helps to keep the lungs open at the end of exhalation while allowing the baby to initiate his/her ...... should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If your asthma symptoms do not improve, or get worse, contact your health ...
... should be monitored by their health care provider. Use ASMANEX as directed by your health care provider, since its ability to work in your lungs depends on regular use. Maximum benefit may take 1 to 2 weeks or longer. If your asthma symptoms do not improve, or get worse, contact your health ...
Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)
... encloses the drug in nanocapsules of lipid called liposomes. This advanced pulmonary liposome technology prolongs the release of amikacin in the lungs while minimizing systemic exposure. The treatment uses biocompatible lipids endogenous to the lung that are formulated into small (0.3 micron), ...... accounting for more than $13 billion in hospitalization costs. The great majority of acute heart failure patients have fluid accumulation in the lungs (congestion) that causes shortness of breath (dyspnea) and other complications. For these patients, the current standard of care includes diuretics ...
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
... aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort ...Doctors Urge Precaution to Shield Against Swine Flu
... and published in Journal of Nutrition, November 2006. Compared with animals exposed to the H1N1 virus without consuming AHCC, the viral load in the lungs of those fed AHCC was 96% lower, their weight was maintained, whereas control group experienced a 19% weight loss, and the AHCC group showed a 27% ...Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... or non-squamous NSCLC, have demonstrated histologic-specific response patterns ranging from a high incidence of severe or fatal bleeding in the lungs to poor response to treatment. Current methods for differentiating squamous from non-squamous NSCLC are not standardized, are difficult to reproduce ...CRESTOR(R) Reduced Risk of Blood Clots in the Veins
... in the 'deep veins' usually in the legs or pelvis. An embolism is created if the clot travels through the venous system. Blood clots lodging in the lungs are known as a pulmonary embolism (PE). Estimates suggest that at least 350,000 and as many as 600,000 Americans annually develop DVT/PE, and at ...... accounting for a total of $13 billion in hospitalization costs. The great majority of acute heart failure patients have fluid accumulation in the lungs (congestion) that causes shortness of breath and other complications. For these patients, the current standard of care includes diuretics and ...
... drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort ...
Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
... circulatory system in the lungs, and, by the use of an external Gamma Camera, allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent ...... drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort ...
... forms in a major vein of the leg, and pulmonary embolism, which occurs when a blood clot detaches from its point of origin and travels to the lungs where it becomes wedged and prevents adequate blood flow, are known collectively as venous thromboembolism. "Venous thromboembolism is a ...
Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
... exacerbations in COPD patients. By delivering the novel MP-376 formulation via the aerosol route, levofloxacin can be delivered directly to the lungs at much higher concentrations than can be achieved through usual oral and intravenous routes of administration. High concentrations are important to ...Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
... orally or intravenously against many bacterial pathogens, including P. aeruginosa. Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug directly to the site of infection, while minimizing systemic exposure. Mpex believes ...... stage research with imatinib mesylate in another non-oncology disease called idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become scarred over time, making it more and more difficult to breathe(6). Early clinical trial results in IPF did not show a significant ...
... from $23 billion in 2007 to $46 billion by 2017. Vectura also develops products for non-respiratory diseases where optimised delivery via the lungs could provide significant benefits, such as a rapid onset of action, improved efficacy and improved tolerability compared with current therapies. ...
Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins
... . Pharmaxis is developing Bronchitol as a treatment to improve mucus clearance in the lungs of patients with cystic fibrosis, bronchiectasis and chronic obstructive airway diseases. Bronchitol is a patented, inhalable dry powder formulation ...Dallas Researchers Find Compression Stockings Improperly Used
... risk for blood clots after surgery because blood tends to pool and coagulate in stationary extremities. These deep vein clots can travel to the lungs and block the pulmonary artery, resulting in a serious and sometimes-fatal complication called a pulmonary embolism. Despite the importance of ...... heart rate -- all of which are symptoms often seen in HF patients, but in many cases, can be managed with medication. The back pressure in the lungs due to the inability of the heart to pump the blood effectively can be measured and transmitted by this device. With this system, pressure data is ...
MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
... tolerated by subjects with compromised lung function, and that the pharmacokinetics of MAP0004 was similar to that experienced by adults with healthy lungs as shown in an earlier Phase 1 study. No serious adverse events were reported. In addition, no clinically significant changes were observed in ...Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
... phase 3 clinical trial is expected to soon close recruitment.'' Pharmaxis is developing Bronchitol as a treatment to improve mucus clearance in the lungs of patients with cystic fibrosis, bronchiectasis and other acute and chronic pulmonary conditions. The U.S. FDA has granted Bronchitol fast track ...... When stimulated by the NeuRx DPS(TM), the diaphragm contracts, mimicking natural breathing, and allows air to fill the upper and lower parts of the lungs rather than forcing air in with a mechanical ventilator. The NeuRx DPS(TM) received the CE Mark (CE Registration #518356) on November 20, 2007 and ...
... the potential value of delivering amikacin through Transave's next-generation liposomal technology." The biofilm is a gel-like matrix in the lungs formed by colonies of the common and often chronic bacterium Pseudomonas aeruginosa, which creates a protective barrier for the bacteria. This ...
Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
... from congestive heart failure, a condition characterized by the inability of the heart to efficiently pump blood and by fluid accumulation in the lungs and other tissues. An estimated 300,000 deaths each year result from heart failure. "The licensing of these novel heart failure drugs greatly ...Other ContentscommunitycommunitycommunitycommunitycommunitycommunitycommunitycommunitycommunitycompanioncompanioncompanioncompanioncompanioncompanioncomparativecomparativecomparativecomparativecomparativecomparativecomparativecomparativecompetentcompetentcompetentcompetentcompetentcompetentcomplementcomplementcomplementcomplementcomplementcomplementcomplementcomplementcomplementcomplementarycomplementarycomplementarycomplementarycomplementarycomplementarycomplementarycomplementarycompositecompositecompositecompositecompositecompositecomplementationcomplementationOther TagsStudStudStudStudStudStudBelieveWearersFranFranFranFestFestRaviRaviOther Tagsworrying 2worrying 3worrying 4worrying 5worrying 6mixing 2causing 2causing 3causing 4causing 5causing 6causing 7causing 8causing 9causing 10blocks 2blocks 3blocks 4blocks 5blocks 6blocks 7blocks 8blocks 9blocks 10compound 2compound 3compound 4compound 5compound 6compound 7compound 8compound 9compound 10screening 2screening 3screening 4screening 5screening 6screening 7screening 8
(Date:12/11/2009)... species of wild apples that could be an ancestor ... and Central Asia. A new study comparing the diversity ... Georgia and Armenia with previously collected varieties originating in ... a core collection that will make M. orientalis ... , To identify and record the genetic diversity of ...
(Date:12/11/2009)... does a cell manage to identify and degrade the ... body against serious diseases? The researchers Sabine C. Horn, ... Jarosch of the Max Delbrck Center for Molecular Medicine ... in this puzzle. In an enzyme complex that plays ... they discovered a scaffold regulating the identification and disposal ...
(Date:12/11/2009)... in French . , Montreal, December ... molecular mechanism that prevents cancer. In the December 11 ... scientists from the Universit de Montral and the Universit ... molecule prevents the cancer-causing activity of cytokines, hormones that ... Crohns, in smokers and people exposed to asbestos. ...
Breaking Biology News(10 mins):Understanding apples' ancestors 2MDC researchers identify a scaffold regulating protein disposal 2Scientists identify natural anti-cancer defenses 2Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Steroid Can Ease Severe Sore Throat 53956 1Steroid Can Ease Severe Sore Throat 53956 2Steroid Can Ease Severe Sore Throat 53956 3Insulet Corporation to Present at Upcoming Investor Conferences 53953 1Insulet Corporation to Present at Upcoming Investor Conferences 53953 2(Date:12/15/2009)... premier manufacturer of Spa, Massage, and Medical tables announces its ... adjustable breast comfort system to ease pressure felt while laying ... ... New Freedom, Pennsylvania (PRWEB) December 15, 2009 -- OAKWORKS®, Inc., ... today announced the launch of the Utopian Massage Table with ...
(Date:12/15/2009)... , ... (PRWEB) December 10, 2009 -- Millions of men and women suffer ... clusters of red, blue or purple veins that spider-web across the nose, ... US, it’s been estimated that 25-30% of women and 10-20% of men ... Veinwave has been available for over 8 years in Europe ...
(Date:12/15/2009)... 15 "The entire San Diego Hospice and ... of Sol Price on December 14, 2009. Mr. Price ... loyalty and ethics in his business, community and personal ... who truly understood the responsibility of philanthropy and the ... will live on through his countless philanthropic efforts. We ...
(Date:12/15/2009)... in the Dec. 15 issue of the ... significant associations exist between parent-reported insomnia symptoms and ... young school-aged children. , Results of multivariate ... times more likely in children with gastrointestinal regurgitation ... headaches. Nineteen percent of children met the ...
(Date:12/14/2009)... New Research Focuses on Unmarried Young Adults, Attitudes and ... ,, WASHINGTON, Dec. 15 Nearly all unmarried ... should be planned (94% of men and 86% of ... pregnancy in their lives right now (86% of men ... by The National Campaign to Prevent Teen and Unplanned ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3[0] Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table[0] Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device [1] San Diego Hospice and The Institute for Palliative Medicine on the Passing of Sol Price[1] Insomnia symptoms linked with medical complaints in young school-aged children[1] Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |